No Picture
News

BioAtla and GATC Health Announce a $40 Million Special Purpose Vehicle (SPV) Transaction to Advance Ozuriftamab Vedotin (Oz-V) into a Registrational Trial for 2L+ Oropharyngeal Squamous Cell Carcinoma (OPSCC)

SAN DIEGO, Dec. 31, 2025 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, and […]

News

HAI Solutions Receives FDA De Novo Grant for QIKCAP System: Pioneering UVC Technology for Microbial Reduction on Needleless IV Connectors

CARLSBAD, Calif., Dec. 30, 2025 /PRNewswire/ — HAI Solutions, a leading innovator in ultraviolet (UVC) microbial reduction medical devices, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo classification for […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Sinopia Biosciences Awarded NIGMS Grant to Advance LEADS® Platform for Data-Driven Drug Discovery

SAN DIEGO–(BUSINESS WIRE)–Sinopia Biosciences, Inc., a biotechnology company advancing novel therapeutics identified using its proprietary LEADS® drug discovery platform, announced today it has been awarded a research grant from the National Institute of General Medical […]

No Picture
News

Health Net Providing Special Assistance to Members Affected by the Atmospheric Rivers Due to the “2025 Late December Storms” in Los Angeles, Orange, Riverside, San Bernardino, San Diego, and Shasta Counties

Health Net Assisting Members During State of Emergency SACRAMENTO, Calif., Dec. 29, 2025 /PRNewswire/ — In response to Gov. Gavin Newsom’s declared state of emergency in Los Angeles, Orange, Riverside, San Bernardino, San Diego, and […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Senhwa Biosciences Aims at Multi-Billion Dollar Global Market with CX-5461 Combined with ADC “Blockbuster” Therapy

TAIPEI and SAN DIEGO, Dec. 28, 2025 /PRNewswire/ — Following its recent clinical collaboration with the multinational pharmaceutical company BeOne Medicines to explore combination therapy with its marketed PD-1 inhibitor in the challenging field of […]

No Picture
News

Singlera Genomics Signs European Distribution and Research Agreement with Pure Medical for Cancer Detection Products

LA JOLLA, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) — Singlera Genomics, a company focused on the development and application of novel DNA methylation technologies to genetic diagnosis, today announced that it has entered into a […]

No Picture
Industry News

Seven Biopharma Trends to Watch in 2026

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last spring. […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

BioMed Realty’s Sustainability Report Emphasizes Long-Term Commitment to Sustainable, Innovative Environments as Recognized by GRESB

SAN DIEGO–(BUSINESS WIRE)–BioMed Realty (“Company”), the largest privately owned operator of real estate for the life science and technology industries in the United States and the United Kingdom, today released its 2024 Sustainability Report, demonstrating […]

No Picture
News

Robles BioCeutics Publishes in Top-Tiered Peer-Reviewed Medical Journal the Scientific Basis for its Novel Age Reversing Skin Care Products

Novel Way of Skin “Time Reversal” Involves Activating Existing Stem Cells in Skin SAN DIEGO, Calif., Dec. 23, 2025 /PRNewswire/ — Robles BioCeutics, a regenerative dermatology company translating senolytic science and stem cell inspired discovery […]

No Picture
News

Senhwa Biosciences Highlights AI-Validated Oncology Platform and Strategic Clinical Collaborations Targeting Next-Generation Immuno-Oncology products at Its 2025 Annual Investor Conference

TAIPEI and SAN DIEGO, Dec. 23, 2025 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage companies focusing on development of first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today outlined continued progress […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Vividion Publishes Discovery of First-in-Class KEAP1 Activator, Supporting Ongoing Clinical Program in Oncology

SAN DIEGO–(BUSINESS WIRE)–Vividion announces publication on discovery and preclinical study of small molecules activating KEAP1 via a covalent molecular glue to degrade NRF2. Click here to view original post Click Here to Publish/Feature Your Company […]


ADVERTISEMENT — Advertise With Biotech Networks
News

PMB Project, Abrazo Health Litchfield Medical Building, Named 2025 HREI Insights™ Award Finalist

Healthcare Real Estate Insights™ magazine’s national awards program honors PMB’s Abrazo Health Litchfield Medical Building, the first combination medical office and inpatient rehabilitation facility in Goodyear, Ariz. SAN DIEGO, Dec. 18, 2025 /PRNewswire/ — PMB’s […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Quantori and Expert Systems Partner to Accelerate Drug Discovery with Foundational Predictive AI Models

CAMBRIDGE, Mass. & SAN DIEGO–(BUSINESS WIRE)–Quantori and Expert Systems partner to integrate foundational predictive AI models into Q-Scientist, accelerating smarter, faster drug discovery. Click here to view original post Click Here to Publish/Feature Your Company […]

News

Innovating Diagnostics and What’s Next

SAN DIEGO, Dec. 18, 2025 /PRNewswire/ — QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 54 of its Science Bytes podcast, featuring Jonathan Siegrist, PhD, Executive Vice President of […]


ADVERTISEMENT — Advertise With Biotech Networks
News

U.S. FDA Approves RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) Co-Formulated with ENHANZE® for the Treatment of Advanced EGFR-mutated Non-Small Cell Lung Cancer

RYBREVANT FASPRO™ is approved across all indications of RYBREVANT® (amivantamab-vmjw) SAN DIEGO, Dec. 18, 2025 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that Johnson & Johnson has received approval from the U.S. […]

No Picture
News

MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy

LA JOLLA, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Singlera Genomics announces research collaboration with the University of Pittsburgh to advance pancreatic cancer early detection

LA JOLLA, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) — Singlera Genomics, a company focused on the application of novel DNA methylation technologies to genetic diagnosis, with their partner Breakthrough Genomics, a leader in the clinical […]